gvtcx

supplier

Novo Nordisk

RH60PA combined from 3 published records

as a supplier

37 recorded awards from 5 buyers , between 14 Aug 2018 and 5 Nov 2025.

awards won
37
exclusive
3%
1 sole-winner awards
median award
£340.3m
largest
£1.1bn

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

contracts won

contractbuyervalueawarded
Insulin Pumps, Continuous Glucose Monitoring, Products Contributing to the Delivery of Hybrid Closed Loop Pathways and Associated Products shared Supply Chain Coordination Limited £1,067,000,000 5 Nov 2025
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National shared NHS England £261,895,933 24 Jun 2025
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender shared NHS England £1,241,520,444 24 Mar 2025
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche shared NHS England £480,429,000 13 Feb 2023
NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche shared NHS England £261,970,000 8 Feb 2023
Integrated Weight Management Services Pathway Redesign for NHS Mid and South Essex Integrated Care Board Attain £201,000 31 Dec 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual shared NHS England £216,078,796 7 Feb 2022
NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche shared NHS England £1 11 Feb 2021
NHS Framework for the NHS London Region, Branded Medicines - Tranche A shared NHS England £191,062,951 16 Jun 2020
NHS National Framework Agreement for the supply of products for the treatment of Haemophilia A shared NHS England £334,400,000 2 Jun 2020
NHS Midlands and East Branded Medicines - Tranche A shared NHS England £418,787,000 15 Jan 2020
NHS South of England Branded Medicines - Tranche A - Contracts Finder Award Notice shared NHS England £188,004,961 31 Jul 2019
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity shared NHS England £251,930,337 4 Jul 2019
NHS Framework agreement for Branded Medicines - North of England - Tranche A shared NHS England £204,551,038 18 Feb 2019
NHS England Framework Agreement: South of England (Tranche B) shared NHS England £501,400,000 13 Sept 2018
NHS England Framework Agreement - London - Tranche A shared NHS England £211,435,404 14 Aug 2018
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 shared NHS England · 21 Jul 2026
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025 shared NHS England · 22 Apr 2025
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 shared NHS England · 11 Jun 2024
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 shared NHS England · 11 Jun 2024
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 shared NHS England · 11 Jun 2024
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 shared NHS England · 11 Jun 2024

every contract won by Novo Nordisk →

as published

This page combines 3 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Novo Nordisk · RH6 0PA 25
Novo Nordisk GB-COH 01118740 RH6 0PA 11
NOVO NORDISK GB-PPON PQLC-7289-YJVN RH6 0PA 1

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works